Texas Cardiac Arrhythmia Recruits Andrea Natale, World’s Foremost Authority on Atrial Fibrillation
Texas Cardiac Arrhythmia (TCA), a division of Texas Cardiovascular Consultants, announced today the addition of Andrea Natale, an international leader in the treatment of heart rhythm disorders. The addition of Dr. Natale solidifies TCA as arguably one of the leading electrophysiology groups in the world.
Before joining TCA, Natale was a member of the Cardiovascular Medicine Department at the Cleveland Clinic from 1999 to October 2007, serving most recently as medical director for the Cleveland Clinic’s Center for Atrial Fibrillation. In 2006, Natale was named to the Food and Drug Administration’s Task Force on Atrial Fibrillation and recently received a patent for a device used to destroy part of the heart that causes Atrial Fibrillation (A-Fib). A pioneer in advancements of cardiac ablation for the treatment of A-Fib, Natale has performing thousands of procedures to help correct heart rhythm disorders. He has written or co-written hundreds of published studies on pacing and electrophysiology.
One of Natale’s primary responsibilities as partner of TCA will be to head up the Texas Cardiac Arrhythmia Institute at St. David’s Medical Center – an international treatment, training and research center specializing in heart rhythm disorders—is the first of its kind in the U.S. Natale was named medical director of The Institute at a press conference at St. David’s Medical Center today.
Born in Siracusa, Italy, Natale graduated from the Medical School of the University of Firenze, Italy, in 1985. After graduating from the Catholic University of the Sacred Heart in Rome, Italy, he completed his clinical training in cardiology at the University of Wisconsin’s Sinai Samaritan Medical Center and the University of Western Ontario. Click here for Dr. Natale’s full bio.